Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-07-13 18:27:21
Reporting Period:
Accepted Time:
2020-07-13 18:27:21
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1280600 Acceleron Pharma Inc XLRN Pharmaceutical Preparations (2834) DE
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
14272 Bristol Myers Squibb Co 430 E. 29Th Street
14 Floor
New York NY 10016
No No Yes No
816284 Celgene Corp /De/ 86 Morris Avenue
Summit NJ 07901
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-07-09 38,979 $5.88 7,010,751 No 4 X Direct
Common Stock Disposition 2020-07-09 2,241 $102.28 7,008,510 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.001 Par Value Option Warrant Disposition 2020-07-09 38,979 $0.00 38,979 $5.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-07-09 No 4 X Direct
  1. This statement is being filed jointly by Celgene Corporation and Bristol-Myers Squibb Company (the "Reporting Persons").
  2. These shares are owned directly by Celgene Corporation, which is a wholly owned subsidiary of Bristol-Myers Squibb Company. Bristol-Myers Squibb Company is an indirect beneficial owner of the reported securities.
  3. On July 9, 2020, the Reporting Persons exercised a warrant to purchase 38,979 shares of the Issuer's common stock for $5.88 per share. The Reporting Persons paid the exercise price on a cashless basis, resulting in the Issuer withholding 2,241 of the warrant shares to pay the exercise price and issuing to the Reporting Persons the remaining 36,738 shares.
  4. All of the shares are currently exercisable.